Peter J. Weiler is appointed CFO of Edesa Biotech starting May 1, 2025, marking a strategic leadership transition. Weiler brings extensive experience from roles in biotech and pharmaceuticals, previously as…
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer, signaling strategic financial enhancement amidst leadership transitions. Weiler's extensive experience in biotech and pharmaceuticals, highlighted by his role at Exzell…
Edesa Biotech appoints Peter J. Weiler as CFO starting May 1, 2025, succeeding Stephen Lemieux. Weiler brings extensive experience from leadership roles at Exzell Pharma and Biosyent Inc., blending scientific…
Edesa Biotech announces Peter J. Weiler as the new CFO, effective May 1, 2025, signaling a pivotal shift in financial strategy. Weiler's extensive experience in the biotech and pharma sectors,…
Peter J. Weiler takes over as CFO of Edesa Biotech, starting May 1, 2025, bringing extensive biotech industry experience. The transition aims to enhance Edesa's financial strategies and align them…
Peter J. Weiler joins Edesa Biotech as Chief Financial Officer in May, marking a pivotal transition for the company and the broader biotech industry. Weiler brings extensive experience from Exzell…
Edesa Biotech appoints Peter J. Weiler as the new Chief Financial Officer, effective May 1, 2025, succeeding Stephen Lemieux. Weiler's extensive background spans key roles at Exzell Pharma, Biosyent Inc.,…
Peter J. Weiler appointed as new CFO of Edesa Biotech, starting May 1, 2025. Weiler brings extensive experience, with previous roles at Exzell Pharma and Biosyent Inc. Weiler holds an…
A pivotal leadership change occurs at Edesa Biotech as Peter J. Weiler is appointed CFO, bringing extensive experience in business development and pharmaceutical leadership. Weiler's background includes key roles at…
Peter J. Weiler joins Edesa Biotech as CFO on May 1, 2025, bringing extensive leadership in biotechnology and pharmaceuticals. Weiler's experience includes roles as President of Exzell Pharma and VP…